Scientists test new gout Drug's safety with common treatment
NCT ID NCT07367971
Summary
This early-stage study aims to understand how a new gout drug, ABP-671, interacts with the standard medication allopurinol when taken together. It will involve about 20 adults with gout who are already taking stable allopurinol therapy. The main goal is to measure drug levels in the blood to see if taking both drugs changes how the body processes either one.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wakefield Clinical Research
Cary, North Carolina, 27560, United States
Contact
Conditions
Explore the condition pages connected to this study.